Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Genzyme Corporation    GENZ

GENZYME CORPORATION

(GENZ)
SummaryNewsCompany 
 News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news
Most relevant news about GENZYME CORPORATION
2011GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society..
PU
2011GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept..
BU
2011GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to Interna..
BU
2011GENZYME CORP.GNL : Genzyme Recognizes International Rare Disease Day by Launchin..
BU
2011GENZYME CORP.GNL : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease..
BU
2011GENZYME CORP.GNL : Genzyme Reports Financial Results for Fourth Quarter of 2010 ..
BU
2011GENZYME CORP.GNL : Genzyme Completes Sale of Diagnostics Business to Sekisui Che..
BU
2011GENZYME CORP.GNL : Genzyme Will Allow Sanofi-Aventis to Conduct Due Diligence
BU
2011GENZYME CORP.GNL : Genzyme to Build Additional Plant to Support Growth of Myozym..
BU
2011GENZYME CORP.GNL : Genzyme Financial Recovery Continues in Fourth Quarter
BU
2011GENZYME CORP.GNL : Genzyme Statement on Discussions With Sanofi-Aventis
BU
2010GENZYME CORP.GNL : Genzyme Details Market Potential of Alemtuzumab for MS
BU
2010GENZYME CORP.GNL : Genzyme to Hold Investor Event on Alemtuzumab
BU
2010GENZYME CORP.GNL : Genzyme Reiterates Board's Position on Sanofi-Aventis Tender ..
BU
2010GENZYME CORP.GNL : Genzyme Completes Sale of Genetic Testing Business to LabCorp
BU
More most relevant news
All news about GENZYME CORPORATION
2011GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society..
PU
2011GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept..
BU
2011GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to Interna..
BU
2011GENZYME CORP.GNL : Genzyme Recognizes International Rare Disease Day by Launchin..
BU
2011GENZYME CORP.GNL : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease..
BU
2011GENZYME CORP.GNL : Genzyme Reports Financial Results for Fourth Quarter of 2010 ..
BU
2011GENZYME CORP.GNL : Genzyme Completes Sale of Diagnostics Business to Sekisui Che..
BU
2011GENZYME CORP.GNL : Genzyme Will Allow Sanofi-Aventis to Conduct Due Diligence
BU
2011GENZYME CORP.GNL : Genzyme to Build Additional Plant to Support Growth of Myozym..
BU
2011GENZYME CORP.GNL : Genzyme Financial Recovery Continues in Fourth Quarter
BU
More news
News in other languages on GENZYME CORPORATION
2011GENZYME : succès de l'OPE de Sanofi-aventis.
2011GENZYME : Sanofi-aventis modifie son offre.
2011GENZYME CORP.GNL : Résultat trimestriel de Genzyme dans la fourchette annoncée
2011GENZYME : racheté par Sanofi-Aventis.
2011GENZYME CORP.GNL : bénéfice inférieur aux attentes
2011GENZYME : proche d'un accord avec Sanofi-Aventis ?
2011GENZYME CORP.GNL : a signé un accord de confidentialité avec SANOFI
2011GENZYME : Sanofi-Aventis prolonge son offre publique d'achat.
2011GENZYME CORP.GNL : L'OPA de Sanofi sur Genzyme devrait réussir, selon le DG d'Is..
2011GENZYME CORP.GNL : Les résultats trimestriels de Genzyme décevants, rien sur San..
Press releases
2011GENZYME CORP.GNL : Mipomersen Data Presented at European Atherosclerosis Society..
PU
2011GENZYME CORP.GNL : Genzyme Board Unanimously Recommends that Shareholders Accept..
BU
2011GENZYME CORP.GNL : Genzyme Completes Sale of Pharmaceuticals Business to Interna..
BU
2011GENZYME CORP.GNL : Genzyme Recognizes International Rare Disease Day by Launchin..
BU
2011GENZYME CORP.GNL : Three-Year Data from Phase 2 Trial of Genzyme Gaucher Disease..
BU
More press releases
Sector news : Bio Therapeutic Drugs
07:17aELI LILLY AND : Lilly, Incyte Say Baricitinib Meets Primary Endpoint in Phase 3 ..
DJ
07:12aAmerica's Gold Giant Bets on Dividends, Improved Mines to Hold Off Rival
DJ
01/22SIERRA ONCOLOGY : Shares Drop 12% Before Reverse Stock Split
DJ
01/22SIERRA ONCOLOGY : Declares 1-for-40 Reverse Stock Split
DJ
01/21FRESENIUS : Kabi Sets up Joint Venture With Bio-Techne, Wilson Wolf
DJ
More sector news : Bio Therapeutic Drugs